CN105219829A - A kind of method preparing 9 Alpha-hydroxies-Androsta-1,4-diene-3,17-dione - Google Patents
A kind of method preparing 9 Alpha-hydroxies-Androsta-1,4-diene-3,17-dione Download PDFInfo
- Publication number
- CN105219829A CN105219829A CN201510666412.3A CN201510666412A CN105219829A CN 105219829 A CN105219829 A CN 105219829A CN 201510666412 A CN201510666412 A CN 201510666412A CN 105219829 A CN105219829 A CN 105219829A
- Authority
- CN
- China
- Prior art keywords
- mycobacterium
- diene
- add
- dione
- hydroxies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 238000000855 fermentation Methods 0.000 claims abstract description 62
- 230000004151 fermentation Effects 0.000 claims abstract description 62
- 241000186359 Mycobacterium Species 0.000 claims abstract description 32
- 244000005700 microbiome Species 0.000 claims abstract description 9
- 239000000758 substrate Substances 0.000 claims abstract description 7
- 241000187693 Rhodococcus rhodochrous Species 0.000 claims description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- 239000002054 inoculum Substances 0.000 claims description 13
- 239000000047 product Substances 0.000 claims description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 11
- 150000001875 compounds Chemical class 0.000 claims description 11
- 239000008103 glucose Substances 0.000 claims description 11
- 239000012065 filter cake Substances 0.000 claims description 9
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 8
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 8
- 238000004821 distillation Methods 0.000 claims description 8
- 238000001914 filtration Methods 0.000 claims description 8
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 claims description 8
- 229940061634 magnesium sulfate heptahydrate Drugs 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 235000016068 Berberis vulgaris Nutrition 0.000 claims description 7
- 241000335053 Beta vulgaris Species 0.000 claims description 7
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 claims description 7
- 229960004642 ferric ammonium citrate Drugs 0.000 claims description 7
- 239000004313 iron ammonium citrate Substances 0.000 claims description 7
- 235000000011 iron ammonium citrate Nutrition 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 5
- 238000009629 microbiological culture Methods 0.000 claims description 3
- -1 polyoxyethylene Polymers 0.000 claims description 3
- 238000007670 refining Methods 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 4
- 235000002378 plant sterols Nutrition 0.000 claims 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 2
- 230000003196 chaotropic effect Effects 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 2
- 101100476962 Drosophila melanogaster Sirup gene Proteins 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 claims 1
- 230000009849 deactivation Effects 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000011591 potassium Substances 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 229940068065 phytosterols Drugs 0.000 abstract description 28
- 238000006243 chemical reaction Methods 0.000 abstract description 23
- 239000002904 solvent Substances 0.000 abstract description 16
- 238000000746 purification Methods 0.000 abstract description 12
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 abstract description 10
- 241000316848 Rhodococcus <scale insect> Species 0.000 abstract description 5
- 239000002609 medium Substances 0.000 description 31
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 21
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 230000009466 transformation Effects 0.000 description 20
- BTTWKVFKBPAFDK-UHFFFAOYSA-N (9beta,10alpha)-Androst-4-ene-3,17-dione Natural products OC1CCC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 BTTWKVFKBPAFDK-UHFFFAOYSA-N 0.000 description 15
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 15
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 15
- 238000004128 high performance liquid chromatography Methods 0.000 description 14
- 238000004809 thin layer chromatography Methods 0.000 description 14
- 230000036983 biotransformation Effects 0.000 description 13
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- 238000011081 inoculation Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 150000003431 steroids Chemical class 0.000 description 10
- 238000005805 hydroxylation reaction Methods 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 description 7
- 238000005119 centrifugation Methods 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 238000004042 decolorization Methods 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 238000012544 monitoring process Methods 0.000 description 7
- 235000019837 monoammonium phosphate Nutrition 0.000 description 7
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 description 7
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000010009 beating Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 235000013379 molasses Nutrition 0.000 description 6
- 238000005273 aeration Methods 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000033444 hydroxylation Effects 0.000 description 5
- 241000187654 Nocardia Species 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- JCEUDJXAQHPZGL-PLOWYNNNSA-N 9alpha-hydroxyandrosta-1,4-diene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@@]3(O)CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JCEUDJXAQHPZGL-PLOWYNNNSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- LUJVUUWNAPIQQI-QAGGRKNESA-N androsta-1,4-diene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 LUJVUUWNAPIQQI-QAGGRKNESA-N 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 235000015278 beef Nutrition 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- SNMVJSSWZSJOGL-PLOWYNNNSA-N 9alpha-hydroxyandrost-4-en-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@@]3(O)CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 SNMVJSSWZSJOGL-PLOWYNNNSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000193744 Bacillus amyloliquefaciens Species 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000187480 Mycobacterium smegmatis Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000703 anti-shock Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法,以植物甾醇为底物,利用分枝杆菌<i>Mycobacterium</i>(CICC?21097)和玫瑰色红球菌<i>Rhodococcus?rhodochrous</i>(CGMCC?4.1480)两种微生物混菌发酵制备9α-羟基-雄甾-1,4-二烯-3,17-二酮。本发明还通过在发酵培养基中添加复合促溶剂,使植物甾醇向9α-OH-ADD的最高摩尔转化率达到84.3%。同时减少了两步法制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法的提纯步骤,降低了溶媒的使用量。
The invention discloses a method for preparing 9α-hydroxy-androst-1,4-diene-3,17-dione, which uses phytosterol as a substrate and utilizes mycobacterium <i>Mycobacterium</i> ( CICC? 21097) and Rhodococcus <i> Rhodococcus? 9α-hydroxy-androst-1,4-diene-3,17-dione was prepared by mixed fermentation of two kinds of microorganisms in rhodochrous</i> (CGMCC? 4.1480). In the present invention, the highest molar conversion rate of phytosterols to 9α-OH-ADD reaches 84.3% by adding complex solubilizers in the fermentation medium. At the same time, the purification steps of the two-step method for preparing 9α-hydroxy-androst-1,4-diene-3,17-dione are reduced, and the amount of solvent used is reduced.
Description
技术领域technical field
本发明属于微生物制药领域,涉及一种9α-羟基-雄甾-1,4-二烯-3,17-二酮,具体来说是一种采用混菌生物转化植物甾醇制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法。The invention belongs to the field of microbial pharmacy, and relates to a 9α-hydroxy-androsta-1,4-diene-3,17-dione, specifically a method for preparing 9α-hydroxy-androsta-1,4-diene-3,17-dione by using mixed bacteria to biotransform phytosterols. The method of ster-1,4-diene-3,17-dione.
背景技术Background technique
甾体化合物(Steroids)又称类固醇,是一类含有环戊烷多氢菲母核的化合物。其基本结构如下所示,由三个六元环和一个五元环组成,分别称为A、B、C、D环,一般在甾体母核的第10和13位上有角甲基(-CH3),第3、9、11位可能有羟基(-OH)或酮基(-C=O),A环或B环存在部分双键,第17位上有长短不同的侧链。由于甾体母核上取代基、双键位置或立体构型等的不同,形成了一系列具有独特生理功能的化合物。Steroids, also known as steroids, are a class of compounds containing cyclopentane polyhydrophenanthrene nuclei. Its basic structure is shown below. It consists of three six-membered rings and one five-membered ring, called A, B, C, and D rings respectively. Generally, there are angular methyl groups on the 10th and 13th positions of the steroid nucleus ( -CH 3 ), there may be a hydroxyl group (-OH) or a keto group (-C=O) at the 3rd, 9th, and 11th positions, some double bonds exist in the A ring or B ring, and there are side chains of different lengths at the 17th position. A series of compounds with unique physiological functions are formed due to the differences in substituents, double bond positions or stereo configurations on the steroidal core.
甾体化合物结构通式General structure of steroids
甾体类药物是医药行业中产量仅次于抗生素的第二大类药物,甾体类药物具有抗过敏、抗休克、抗炎症、抗变态反应等多种功效,被广泛用于治疗支气管哮喘、风湿性关节炎、湿疹、贫血以及促进骨折和伤口的愈合,也被用于治疗艾迪森氏等内分泌疾病,对机体发展、免疫调节、皮肤疾病治疗及生育控制方面有重要的作用。甾体类药物对激素依赖型肿瘤的治疗有一定的疗效。随着甾体化学的迅速发展,甾体激素类药物己成为医药领域的重要门类,在临床上的应用非常广泛。Steroid drugs are the second largest class of drugs in the pharmaceutical industry after antibiotics. Steroid drugs have various functions such as anti-allergic, anti-shock, anti-inflammation, and anti-allergic reactions. They are widely used in the treatment of bronchial asthma, Rheumatoid arthritis, eczema, anemia, and the promotion of fracture and wound healing are also used to treat endocrine diseases such as Addison's, and play an important role in body development, immune regulation, skin disease treatment, and birth control. Steroids are effective in the treatment of hormone-dependent tumors. With the rapid development of steroid chemistry, steroid hormone drugs have become an important category in the field of medicine, and are widely used in clinical practice.
目前,关于微生物法转化甾体药物的新菌种及新技术研究发展态势良好。9α-OH-ADD及9α-OH-ADD作为合成甾体类药物的重要原料和关键中间体,受到较多研究者的青睐。At present, the research and development of new strains and new technologies for the transformation of steroidal drugs by microbial methods is in good shape. 9α-OH-ADD and 9α-OH-ADD are important raw materials and key intermediates for the synthesis of steroid drugs, and are favored by many researchers.
国内外研究工作在相关领域主要集中在利用植物甾醇制备雄甾-4-烯-3,17-二酮(4-AD)或雄甾-1,4-二烯-3,17-二酮(ADD),及运用诺卡氏菌或红球菌等菌种对4-AD或ADD进行C9α羟基化制备9α-羟基-雄甾-4-烯-3,17-二酮(9α-OH-AD)或9α-羟基-雄甾-1,4-二烯-3,17-二酮(9α-OH-ADD)。Research work at home and abroad mainly focuses on the preparation of androst-4-ene-3,17-dione (4-AD) or androst-1,4-diene-3,17-dione ( ADD), and the use of bacteria such as Nocardia or Rhodococcus to carry out C 9α hydroxylation of 4-AD or ADD to prepare 9α-hydroxyl-androst-4-ene-3,17-dione (9α-OH-AD ) or 9α-hydroxy-androst-1,4-diene-3,17-dione (9α-OH-ADD).
(1)甾醇制备4-AD或ADD(1) Preparation of 4-AD or ADD from sterols
用于甾醇侧链降解的微生物主要有分枝杆菌(Mycobacterium)、诺卡氏菌(Nocardia)、节杆菌(Arthrobacterium)、短杆菌(Brevibacterium)等。众多文献及专利中显示,在利用植物甾醇进行侧链降解过程中都会同时生成4-AD和ADD,两者的生成质量比根据菌种及生产工艺的不同具有一定差异。如专利CN104403974A中采用解淀粉芽孢杆菌对植物甾醇进行边链降解,4-AD与ADD生成的质量比为18:1;专利CN1544618A中利用Mycobacteriumsp.NRRLB3683对胆固醇进行边链切除,生成的4-AD和ADD质量比为1:10。转化时间一般均在100-120h。The microorganisms used for the degradation of sterol side chains mainly include Mycobacterium, Nocardia, Arthrobacterium, Brevibacterium and the like. Numerous literatures and patents have shown that 4-AD and ADD will be produced simultaneously during the side chain degradation process using phytosterols, and the production mass ratio of the two will vary depending on the strain and production process. For example, in patent CN104403974A, Bacillus amyloliquefaciens is used to degrade phytosterols by side chains, and the mass ratio of 4-AD to ADD is 18:1; in patent CN1544618A, Mycobacteriumsp. The mass ratio to ADD is 1:10. The conversion time is generally 100-120h.
(2)4-AD或ADD制备9α-OH-AD或9α-OH-ADD(2) 4-AD or ADD to prepare 9α-OH-AD or 9α-OH-ADD
用于甾体9α-羟基化反应的微生物主要有红球菌(Rhodococcus)、棒杆菌(Corynebacterium)、诺卡氏菌(Nocardia)等。如专利CN103667126A介绍了一种利用耻垢分枝杆菌制备9α-OH-AD的方法;专利CN103343155A中公布了一种利用偶发分枝杆菌制备9α-羟基雄烯二酮的方法。转化时间一般在96-100h左右。The microorganisms used for the steroid 9α-hydroxylation reaction mainly include Rhodococcus, Corynebacterium, Nocardia and the like. For example, patent CN103667126A introduces a method for preparing 9α-OH-AD by using Mycobacterium smegmatis; patent CN103343155A discloses a method for preparing 9α-hydroxyandrostenedione by using Mycobacterium fortuitousus. The conversion time is generally around 96-100h.
综上所述,就目前文献及专利来看,利用植物甾醇生物法制备9α-OH-ADD,需要通过两步发酵来完成(即两步法),目前未见利用植物甾醇一步法制备9α-OH-ADD的文献报道。两步法一般先利用分枝杆菌将植物甾醇转化为ADD,再经提取、精制得到ADD,之后再利用诺卡氏菌或红球菌等菌株对ADD进行9α-羟基化得到9α-OH-ADD。但上述的两步法存在如下不足:①植物甾醇向ADD方向转化时,植物甾醇的利用效率偏低。②侧链降解发酵过程生成的产物均同时含有4-AD及ADD,由于4-AD与ADD的结构相近,因此很难进行分离纯化。③产物ADD后期提取纯化需要利用大量的合适的有机溶剂进行提取精制,以得到纯度较高的ADD,才能作为后续的9α-羟基化的底物。所以,开发更加高效省时的工业化生物法制备9α-OH-ADD的方法具有很高的应用价值和前景。In summary, based on the current literature and patents, the preparation of 9α-OH-ADD by using phytosterol biological method needs to be completed by two-step fermentation (i.e. two-step method). OH-ADD reported in the literature. The two-step method generally uses mycobacteria to convert phytosterols into ADD, and then extracts and refines ADD to obtain ADD, and then uses Nocardia or Rhodococcus strains to perform 9α-hydroxylation of ADD to obtain 9α-OH-ADD. However, the above-mentioned two-step method has the following disadvantages: ① When phytosterols are converted to ADD direction, the utilization efficiency of phytosterols is low. ② The products generated during the side chain degradation fermentation process all contain 4-AD and ADD at the same time. Since 4-AD and ADD have similar structures, it is difficult to separate and purify. ③ The later extraction and purification of the product ADD requires the use of a large amount of suitable organic solvents for extraction and purification to obtain ADD with higher purity, which can be used as a substrate for subsequent 9α-hydroxylation. Therefore, the development of a more efficient and time-saving industrial biological method for preparing 9α-OH-ADD has high application value and prospects.
发明内容Contents of the invention
针对现有技术中的上述技术问题,本发明提供了一种制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法,所述的这种制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法解决了现有技术中采用两步发酵来制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法转化率低、分离纯化困难的技术问题。Aiming at the above-mentioned technical problems in the prior art, the present invention provides a method for preparing 9α-hydroxy-androst-1,4-diene-3,17-dione, the preparation of 9α-hydroxy- The method of androst-1,4-diene-3,17-dione solves the problem of using two-step fermentation in the prior art to prepare 9α-hydroxy-androst-1,4-diene-3,17-dione The method has the technical problems of low conversion rate and difficult separation and purification.
本发明提供了一种制备9α-羟基-雄甾-1,4-二烯-3,17-二酮的方法,以植物甾醇为底物,利用分枝杆菌Mycobacterium和玫瑰色红球菌Rhodococcusrhodochrous两种微生物混菌发酵制备9α-羟基-雄甾-1,4-二烯-3,17-二酮。The invention provides a method for preparing 9α-hydroxy-androst-1,4-diene-3,17-dione, which uses phytosterol as a substrate and uses two kinds of mycobacterium Mycobacterium and Rhodococcus rhodochrous Preparation of 9α-hydroxy-androst-1,4-diene-3,17-dione by mixed microbial fermentation.
进一步的,所述的方法包括如下步骤:Further, the method includes the following steps:
1)一个配制含有植物甾醇的发酵培养基的步骤;1) a step of preparing a fermentation medium containing phytosterols;
2)在所述的发酵培养基中加入复合促溶剂,所述的复合促溶剂由乙醇和聚乙二醇组成,在所述的发酵培养基中,所述的乙醇的浓度为10.0-50.0g/L,所述的聚乙二醇的浓度为5.0-20.0g/L;2) Adding a composite solubilizer in the fermentation medium, the composite solubilizer is composed of ethanol and polyethylene glycol, in the fermentation medium, the concentration of the ethanol is 10.0-50.0g /L, the concentration of the polyethylene glycol is 5.0-20.0g/L;
3)一个分别接种分枝杆菌Mycobacterium和玫瑰色红球菌Rhodococcusrhodochrous的步骤,所述的分枝杆菌Mycobacterium的接种量为10.0-15.0%,转化培养0-48h后,再接入10.0-20.0%玫瑰色红球菌Rhodococcusrhodochrous,发酵温度为28-32℃,发酵时间为72-120h,发酵培养基pH在6.5-7.5之间;3) A step of inoculating Mycobacterium and Rhodococcus rhodochrous respectively, the inoculum amount of Mycobacterium is 10.0-15.0%, and after 0-48 hours of transformation culture, 10.0-20.0% rose For Rhodococcus rhodochrous, the fermentation temperature is 28-32°C, the fermentation time is 72-120h, and the pH of the fermentation medium is between 6.5-7.5;
4)一个产物提取精制的步骤,发酵结束后,将发酵液70-90℃灭活,冷却到20-30℃后,板框压滤,取滤饼进行萃取,再经过滤、脱色、蒸馏、精制,得到9α-羟基-雄甾-1,4-二烯-3,17-二酮。进一步的,所述发酵培养基的配方如下:葡萄糖10.0-30.0g/L,磷酸二氢铵2.0-4.0g/L,柠檬酸铁铵0.03-0.08g/L,七水硫酸镁1.5-3.5g/L,磷酸氢二钾0.5-1.5g/L,磷酸二氢钾0.5-1.5g/L,甜菜糖蜜5.0-9.0g/L,植物甾醇30.0-40.0g/L。4) A step of extracting and refining the product. After the fermentation is completed, inactivate the fermentation broth at 70-90°C, cool it to 20-30°C, press filter with plate and frame, take the filter cake for extraction, and then filter, decolorize, distill, Refined to obtain 9α-hydroxy-androst-1,4-diene-3,17-dione. Further, the formula of the fermentation medium is as follows: glucose 10.0-30.0g/L, ammonium dihydrogen phosphate 2.0-4.0g/L, ferric ammonium citrate 0.03-0.08g/L, magnesium sulfate heptahydrate 1.5-3.5g /L, dipotassium hydrogen phosphate 0.5-1.5g/L, potassium dihydrogen phosphate 0.5-1.5g/L, beet molasses 5.0-9.0g/L, phytosterol 30.0-40.0g/L.
进一步的,所述的分枝杆菌Mycobacterium的保藏号为CICC21097,来自中国工业微生物菌种保藏管理中心;所述的玫瑰色红球菌Rhodococcusrhodochrous的保藏号为CGMCC4.1480,来自中国普通微生物菌种保藏管理中心。Further, the preservation number of the Mycobacterium Mycobacterium is CICC21097 from the China Industrial Microorganism Culture Collection Management Center; the preservation number of the Rhodococcus rhodochrous is CGMCC4.1480 from the China General Microbiology Culture Collection Management Center. center.
本发明以植物甾醇为底物,利用分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)两种微生物混菌发酵制备9α-OH-ADD,还通过在发酵培养基中添加复合促溶剂,对植物甾醇进行生物转化,使植物甾醇侧链降解与C9α位羟基化一步完成,使植物甾醇向9α-OH-ADD的最高摩尔转化率达到84.3%。The present invention uses phytosterol as a substrate, utilizes Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) to prepare 9α-OH-ADD through mixed fermentation of two microorganisms, and also adds compound Solubilizer, biotransforms phytosterols, completes the degradation of phytosterol side chains and C 9α -position hydroxylation in one step, and makes the highest molar conversion rate of phytosterols to 9α-OH-ADD reach 84.3%.
本发明的方法与两步法(即先使植物甾醇生物转化为ADD,再以ADD为底物,在其C9α位羟基化得到9α-OH-ADD)相比有如下优点:(1)一步法混菌转化植物甾醇制备9α-OH-ADD,其羟基化过程更加有利于植物甾醇向ADD方向转化,提高植物甾醇的利用效率。(2)减少提纯步骤,去掉了两步法中ADD的提取纯化过程,使两步提纯变为一步,降低溶媒使用量。(3)减少副产物4-AD及9α-OH-AD的产生,提高植物甾醇向9α-OH-ADD的生物转化率,缩短生物发酵周期。The method of the present invention has following advantage compared with two-step method (promptly make phytosterol biotransformation into ADD earlier, then use ADD as substrate, obtain 9α-OH-ADD at its C 9α position hydroxylation): (1) one-step 9α-OH-ADD is prepared by using mixed bacteria to transform phytosterols. The hydroxylation process is more conducive to the conversion of phytosterols to ADD and improves the utilization efficiency of phytosterols. (2) The purification steps are reduced, the extraction and purification process of ADD in the two-step method is removed, the two-step purification is changed into one step, and the solvent usage is reduced. (3) Reduce the production of by-products 4-AD and 9α-OH-AD, increase the biotransformation rate of phytosterols to 9α-OH-ADD, and shorten the biological fermentation cycle.
本发明利用两菌株之间协同作用的优点,促使植物甾醇更多的向9α-OH-ADD进行转化,减少副产物4-AD和9α-OH-AD的产生,提高植物甾醇向9α-OH-ADD的生物效率,缩短生物发酵周期,较大程度降低生产成本的效果。The present invention utilizes the advantages of the synergistic effect between the two bacterial strains to promote the conversion of phytosterols to 9α-OH-ADD, reduce the production of by-products 4-AD and 9α-OH-AD, and increase the conversion of phytosterols to 9α-OH-ADD. The biological efficiency of ADD shortens the biological fermentation cycle and greatly reduces the production cost.
本发明和已有技术相比,其技术进步是显著的。本发明采用一步法转化,减少了提纯步骤,即去掉了两步法中ADD的提取纯化过程,使两步提纯变为一步,大大降低溶媒使用量,降低了生产成本。Compared with the prior art, the technical progress of the present invention is remarkable. The present invention adopts a one-step conversion method, reduces the purification steps, that is, eliminates the extraction and purification process of ADD in the two-step method, makes the two-step purification into one step, greatly reduces the amount of solvent used, and reduces the production cost.
附图说明Description of drawings
图1显示了混菌生物转化植物甾醇制备9α-OH-ADD的过程。Figure 1 shows the process of preparing 9α-OH-ADD by biotransforming phytosterols with mixed bacteria.
具体实施方式detailed description
下面通过具体实施例对本发明进一步阐述,但并不限制本发明。The present invention is further illustrated below by specific examples, but the present invention is not limited.
本发明采用的分枝杆菌Mycobacterium(CICC21097)是公开销售的微生物,来自,中国工业微生物菌种保藏管理中心,该机构的地址为:北京市朝阳区酒仙桥中路24号院6号楼(100015),可以通过电话购买,也可以通过网站订购(http://www.china-cicc.org),任何人只要支付相关的费用均可以购买。The Mycobacterium Mycobacterium (CICC21097) that the present invention adopts is the microorganism of public sale, comes from, China Industrial Microorganism Strain Preservation Management Center, the address of this institution is: No. 6 Building (100015), No. 24 Courtyard, Jiuxianqiao Middle Road, Chaoyang District, Beijing , can be purchased by phone, or through the website (http://www.china-cicc.org), anyone can purchase as long as they pay the relevant fees.
本发明采用的玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)是公开销售的微生物,来自,中国普通微生物菌种保藏管理中心,该机构的地址为:北京市朝阳区北辰西路1号院3号中国科学院微生物研究所,可以通过电话购买,也可以通过网站订购(http://www.cgmcc.net),任何人只要支付相关的费用均可以购买。The rhodococcus rhodochrous (CGMCC4.1480) that the present invention adopts is the microorganism of public sale, comes from, China common microbial culture preservation and management center, the address of this organization is: No. 3, courtyard No. 1, Beichen West Road, Chaoyang District, Beijing, China The Institute of Microbiology, Academy of Sciences, can be purchased by phone or through the website (http://www.cgmcc.net). Anyone can purchase it as long as they pay the relevant fees.
实施例1Example 1
分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)通过斜面培养和种子培养,得到发酵所需要的菌种。一、分枝杆菌Mycobacterium(CICC21097)斜面菌种及种子液制备Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) were cultured on slant and seeds to obtain the strains required for fermentation. 1. Preparation of mycobacterium Mycobacterium (CICC21097) slant strain and seed solution
(1)斜面培养(1) Incline cultivation
斜面培养基:蛋白胨5.0g/L,牛肉膏3.0g/L,氯化钠5.0g/L,葡萄糖10.0g/L,琼脂20.0g/L,29℃条件下培养5-7天。Slant medium: peptone 5.0g/L, beef extract 3.0g/L, sodium chloride 5.0g/L, glucose 10.0g/L, agar 20.0g/L, cultured at 29°C for 5-7 days.
(2)种子培养(2) Seed cultivation
种子培养基:葡萄糖15.0g/L,蛋白胨5.0g/L,牛肉膏3.0g/L,氯化钠5.0g/L,七水硫酸镁2.5g/L,磷酸二氢铵3.5g/L,磷酸氢二钾1.0g/L,磷酸二氢钾1.0g/L,pH7.0,121℃湿热灭菌30min。Seed medium: glucose 15.0g/L, peptone 5.0g/L, beef extract 3.0g/L, sodium chloride 5.0g/L, magnesium sulfate heptahydrate 2.5g/L, ammonium dihydrogen phosphate 3.5g/L, phosphoric acid Dipotassium hydrogen 1.0g/L, potassium dihydrogen phosphate 1.0g/L, pH 7.0, sterilized by moist heat at 121°C for 30min.
将步骤(1)培养的菌株,在无菌条件下用接种环接种2环于装有50mL种子培养基的250mL的摇瓶中,30℃条件下,旋转式摇床200r/min培养48h,制得种子液。The bacterial strain cultivated in step (1) was inoculated under sterile conditions with an inoculation loop into a 250mL shake flask containing 50mL seed medium, and cultivated on a rotary shaker at 200r/min for 48h at 30°C to prepare Get the seed liquid.
二、玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)斜面菌种及种子液制备2. Preparation of Rhodococcus rhodochrous (CGMCC4.1480) slant strain and seed solution
(1)斜面培养(1) Incline cultivation
斜面培养基:葡萄糖10.0g/L,胰蛋白胨15.0g/L,大豆蛋白胨5.0g/L,氯化钠5.0g/L,琼脂20.0g/L,30℃条件下培养5-6天。Slant medium: glucose 10.0g/L, tryptone 15.0g/L, soybean peptone 5.0g/L, sodium chloride 5.0g/L, agar 20.0g/L, cultured at 30°C for 5-6 days.
(2)种子培养(2) Seed cultivation
种子培养基:葡萄糖10.0g/L,酵母膏20.0g/L,鱼蛋白胨5.0g/L,玉米淀粉9.0g/L,磷酸氢二钾2.5g/L,pH7.0,121℃湿热灭菌30min。Seed medium: glucose 10.0g/L, yeast extract 20.0g/L, fish peptone 5.0g/L, corn starch 9.0g/L, dipotassium hydrogen phosphate 2.5g/L, pH 7.0, 121°C damp heat sterilization for 30min .
将步骤(1)培养的菌株,在无菌条件下用接种环接种1环于装有50mL种子培养基的250mL的摇瓶中,30℃条件下,旋转式摇床200r/min培养30h,制得种子液。The bacterial strain cultivated in step (1) was inoculated with an inoculation loop under sterile conditions in a 250mL shake flask containing 50mL seed medium, and cultivated for 30h on a rotary shaker at 200r/min at 30°C to prepare Get the seed solution.
三、发酵培养3. Fermentation
发酵培养基:植物甾醇35.0g/L,葡萄糖21.0g/L,磷酸二氢铵3.5g/L,柠檬酸铁铵0.05g/L,七水硫酸镁2.0g/L,磷酸氢二钾1.2g/L,磷酸二氢钾1.0g/L,甜菜糖蜜6.0g/L,pH7.0。Fermentation medium: phytosterol 35.0g/L, glucose 21.0g/L, ammonium dihydrogen phosphate 3.5g/L, ferric ammonium citrate 0.05g/L, magnesium sulfate heptahydrate 2.0g/L, dipotassium hydrogen phosphate 1.2g /L, potassium dihydrogen phosphate 1.0g/L, beet molasses 6.0g/L, pH7.0.
将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇30.0g/L,聚乙二醇10.0g/L。再进行接种,分枝杆菌MycobacteriumCICC(21097)的接种量为12.0%,在分枝杆菌接种的同时接种玫瑰色红球菌,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为17.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在30℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养96h,取样TLC分析,无植物甾醇斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为17.5g/L,9α-OH-AD的含量为0.25g/L,植物甾醇摩尔转化率为72.4%。At the beginning of the culture, a complex solubilizing agent was added to the medium: ethanol 30.0g/L, polyethylene glycol 10.0g/L. Carry out inoculation again, the inoculation amount of mycobacterium MycobacteriumCICC (21097) is 12.0%, inoculate Rhodococcus rhodochrous when mycobacterium inoculates, the inoculum amount of Rhodococcus rhodochrous (CGMCC4.1480) is 17.0%, uses 5L The fermenter was used for biotransformation, with a liquid filling capacity of 70%, an aeration rate of 1.0 v/v min, a temperature controlled at 30° C., and a rotational speed of 300 r/min. During the conversion period, samples were taken every 12 hours for TLC monitoring. Fermented and cultured for 96 hours, sampled for TLC analysis, there were no phytosterol spots, and the transformation was basically completed. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high performance liquid chromatography. The content of 9α-OH-ADD in the above-mentioned obtained fermentation broth is 17.5g/L, and the content of 9α-OH-AD is 0.25g/L , the molar conversion rate of phytosterol was 72.4%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品。高效液相色谱法分析纯度为98.7%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. Refined by beating with toluene to finally obtain the fine product of 9α-OH-ADD. The analytical purity by high performance liquid chromatography was 98.7%.
实施例2Example 2
将分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)菌株制成种子液(方法同实施例1),然后进行发酵培养。Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) strains were prepared into seed liquid (the method is the same as in Example 1), and then fermented.
发酵培养基:植物甾醇35.0g/L、乙醇31.0g/L,聚乙二醇9.0g/L,葡萄糖20.0g/L,磷酸二氢铵3.0g/L,柠檬酸铁铵0.05g/L,七水硫酸镁2.5g/L,磷酸氢二钾1.0g/L,磷酸二氢钾1.0g/L,甜菜糖蜜6.0g/L,pH7.0。Fermentation medium: phytosterol 35.0g/L, ethanol 31.0g/L, polyethylene glycol 9.0g/L, glucose 20.0g/L, ammonium dihydrogen phosphate 3.0g/L, ferric ammonium citrate 0.05g/L, Magnesium sulfate heptahydrate 2.5g/L, dipotassium hydrogen phosphate 1.0g/L, potassium dihydrogen phosphate 1.0g/L, beet molasses 6.0g/L, pH7.0.
将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇31.0g/L,聚乙二醇9.0g/L。再进行接种,分枝杆菌MycobacteriumCICC(21097)的接种量为12.0%,在分枝杆菌转化培养24h后接种玫瑰色红球菌,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为18.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在30℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养96h,取样TLC分析,无植物甾醇斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为20.4g/L,9α-OH-AD的含量为0.19g/L,植物甾醇摩尔转化率为84.3%。At the beginning of the culture, a compound solubilizing agent was added to the medium: ethanol 31.0 g/L, polyethylene glycol 9.0 g/L. Carry out inoculation again, the inoculum size of mycobacterium MycobacteriumCICC (21097) is 12.0%, inoculate Rhodococcus rhodochrous after mycobacterium transformation culture 24h, the inoculum size of Rhodococcus rhodochrous (CGMCC4.1480) is 18.0%, use A 5L fermenter was used for biotransformation, with a liquid volume of 70%, an aeration rate of 1.0v/v·min, a temperature controlled at 30°C, and a rotational speed of 300r/min. During the transformation period, samples were taken every 12 hours for TLC monitoring. Fermented and cultured for 96 hours, sampled for TLC analysis, there were no phytosterol spots, and the transformation was basically completed. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high performance liquid chromatography. The content of 9α-OH-ADD in the above-mentioned obtained fermentation broth is 20.4g/L, and the content of 9α-OH-AD is 0.19g/L , the molar conversion rate of phytosterols was 84.3%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品,高效液相色谱法分析纯度为99.1%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. It was refined by beating with toluene to finally obtain the refined product of 9α-OH-ADD, the purity of which was analyzed by high performance liquid chromatography was 99.1%.
实施例3Example 3
分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)菌株制成种子液(方法同实施例1),然后进行发酵培养。Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) strains were used to prepare seed liquid (the method is the same as in Example 1), and then fermented.
发酵培养基:植物甾醇35.0g/L,葡萄糖22.0g/L,磷酸二氢铵3.0g/L,柠檬酸铁铵0.05g/L,七水硫酸镁2.0g/L,磷酸氢二钾1.0g/L,磷酸二氢钾1.0g/L,甜菜糖蜜6.0g/L,pH7.0。Fermentation medium: phytosterol 35.0g/L, glucose 22.0g/L, ammonium dihydrogen phosphate 3.0g/L, ferric ammonium citrate 0.05g/L, magnesium sulfate heptahydrate 2.0g/L, dipotassium hydrogen phosphate 1.0g /L, potassium dihydrogen phosphate 1.0g/L, beet molasses 6.0g/L, pH7.0.
将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇30.0g/L,聚乙二醇9.0g/L。再进行接种,分枝杆菌MycobacteriumCICC(21097)的接种量为13.0%,在分枝杆菌转化培养48h后接种玫瑰色红球菌,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为17.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在30℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养96h,取样TLC分析,无植物甾醇斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为18.3g/L,9α-OH-AD的含量为0.31g/L,植物甾醇摩尔转化率为75.7%。At the beginning of the culture, a compound solubilizing agent was added to the medium: ethanol 30.0g/L, polyethylene glycol 9.0g/L. Carry out inoculation again, the inoculum size of mycobacterium MycobacteriumCICC (21097) is 13.0%, inoculate Rhodococcus rhodochrous after mycobacterium transformation culture 48h, the inoculum size of Rhodococcus rhodochrous (CGMCC4.1480) is 17.0%, use A 5L fermenter was used for biotransformation, with a liquid volume of 70%, an aeration rate of 1.0v/v·min, a temperature controlled at 30°C, and a rotational speed of 300r/min. During the transformation period, samples were taken every 12 hours for TLC monitoring. Fermented and cultured for 96 hours, sampled for TLC analysis, there were no phytosterol spots, and the transformation was basically completed. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high performance liquid chromatography. The content of 9α-OH-ADD in the above-mentioned obtained fermentation broth is 18.3g/L, and the content of 9α-OH-AD is 0.31g/L , the molar conversion rate of phytosterol was 75.7%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品,高效液相色谱法分析纯度为98.6%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. It was refined by beating with toluene to finally obtain the refined product of 9α-OH-ADD, the purity of which was analyzed by high performance liquid chromatography was 98.6%.
实施例4Example 4
分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)菌株制成种子液(方法同实施例1),然后进行发酵培养。Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) strains were used to prepare seed liquid (the method is the same as in Example 1), and then fermented.
发酵培养基:植物甾醇30.0g/L,葡萄糖10.0g/L,磷酸二氢铵2.0g/L,柠檬酸铁铵0.08g/L,七水硫酸镁3.5g/L,磷酸氢二钾1.5g/L,磷酸二氢钾1.5g/L,甜菜糖蜜9.0g/L,pH7.5。Fermentation medium: phytosterol 30.0g/L, glucose 10.0g/L, ammonium dihydrogen phosphate 2.0g/L, ferric ammonium citrate 0.08g/L, magnesium sulfate heptahydrate 3.5g/L, dipotassium hydrogen phosphate 1.5g /L, potassium dihydrogen phosphate 1.5g/L, beet molasses 9.0g/L, pH7.5.
将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇10.0g/L,聚乙二醇5.0g/L。再进行接种,分枝杆菌MycobacteriumCICC(21097)的接种量为10.0%,在分枝杆菌转化培养24h后接种玫瑰色红球菌,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为10.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在28℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养72h,取样TLC分析,无植物甾醇斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为17.1g/L,9α-OH-AD的含量为0.20g/L,植物甾醇摩尔转化率为82.5%。At the beginning of the culture, a compound solubilizing agent was added to the medium: ethanol 10.0g/L, polyethylene glycol 5.0g/L. Carry out inoculation again, the inoculum size of mycobacterium MycobacteriumCICC (21097) is 10.0%, inoculate Rhodococcus rhodochrous after mycobacterium transformation culture 24h, the inoculum size of Rhodococcus rhodochrous (CGMCC4.1480) is 10.0%, use A 5L fermenter was used for biotransformation, with a liquid volume of 70%, an aeration rate of 1.0v/v·min, a temperature controlled at 28°C, and a rotational speed of 300r/min. During the transformation period, samples were taken every 12 hours for TLC monitoring. After 72 hours of fermentation, sampling and TLC analysis showed that there were no phytosterol spots, and the transformation was basically completed. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high-performance liquid chromatography. The content of 9α-OH-ADD in the fermentation broth obtained above is 17.1g/L, and the content of 9α-OH-AD is 0.20g/L , the molar conversion rate of phytosterol was 82.5%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品,高效液相色谱法分析纯度为98.8%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. It was refined by beating with toluene to finally obtain the refined product of 9α-OH-ADD, the purity of which was analyzed by high performance liquid chromatography was 98.8%.
实施例5Example 5
分枝杆菌Mycobacterium(CICC21097)和玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)菌株制成种子液(方法同实施例1),然后进行发酵培养。Mycobacterium Mycobacterium (CICC21097) and Rhodococcus rhodochrous (CGMCC4.1480) strains were used to prepare seed liquid (the method is the same as in Example 1), and then fermented.
发酵培养基:植物甾醇40.0g/L,葡萄糖30.0g/L,磷酸二氢铵4.0g/L,柠檬酸铁铵0.03g/L,七水硫酸镁1.5g/L,磷酸氢二钾0.5g/L,磷酸二氢钾0.5g/L,甜菜糖蜜5.0g/L,pH6.5。Fermentation medium: phytosterol 40.0g/L, glucose 30.0g/L, ammonium dihydrogen phosphate 4.0g/L, ferric ammonium citrate 0.03g/L, magnesium sulfate heptahydrate 1.5g/L, dipotassium hydrogen phosphate 0.5g /L, potassium dihydrogen phosphate 0.5g/L, beet molasses 5.0g/L, pH6.5.
将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇50.0g/L,聚乙二醇20.0g/L。再进行接种,分枝杆菌MycobacteriumCICC(21097)的接种量为15.0%,在分枝杆菌转化培养24h后接种玫瑰色红球菌,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为20.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在32℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养120h,取样TLC分析,无植物甾醇斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为21.5g/L,9α-OH-AD的含量为0.24g/L,植物甾醇摩尔转化率为77.8%。At the beginning of the culture, a compound solubilizing agent was added to the culture medium: ethanol 50.0g/L, polyethylene glycol 20.0g/L. Carry out inoculation again, the inoculum size of mycobacterium MycobacteriumCICC (21097) is 15.0%, inoculate Rhodococcus rhodochrous after mycobacterium transformation culture 24h, the inoculum size of Rhodococcus rhodochrous (CGMCC4.1480) is 20.0%, use A 5L fermenter was used for biotransformation, with a liquid volume of 70%, an aeration rate of 1.0v/v·min, a temperature controlled at 32°C, and a rotational speed of 300r/min. During the transformation period, samples were taken every 12h for TLC monitoring. After 120 hours of fermentation, sampling and TLC analysis showed that there were no phytosterol spots, and the transformation was basically completed. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high performance liquid chromatography. The content of 9α-OH-ADD in the above-mentioned obtained fermentation broth is 21.5g/L, and the content of 9α-OH-AD is 0.24g/L , the molar conversion rate of phytosterol was 77.8%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品,高效液相色谱法分析纯度为98.1%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. It was refined by beating with toluene to finally obtain the refined product of 9α-OH-ADD, the purity of which was analyzed by high performance liquid chromatography was 98.1%.
对比实施例1Comparative Example 1
分枝杆菌Mycobacterium(CICC21097)菌株制成种子液(方法同实施例1),然后进行发酵培养。The mycobacterium Mycobacterium (CICC21097) strain is prepared into a seed solution (the method is the same as in Example 1), and then fermented.
发酵培养基如实施例2所述,将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermentation medium was as described in Example 2, and the fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇31.0g/L,聚乙二醇9.0g/L。再进行接种,分枝杆菌Mycobacterium(CICC21097)的接种量为12.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在30℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养96h,取样TLC分析,转化停滞。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中ADD的含量为16.7g/L,4-AD的含量为0.87g/L,植物甾醇摩尔转化率为72.9%。At the beginning of the culture, a compound solubilizing agent was added to the medium: ethanol 31.0 g/L, polyethylene glycol 9.0 g/L. Carry out inoculation again, the inoculum amount of mycobacterium Mycobacterium (CICC21097) is 12.0%, uses 5L fermenter to carry out biotransformation, and liquid filling capacity is 70%, and ventilation rate is 1.0v/v·min, and temperature is controlled at 30 ℃, rotating speed The temperature was 300r/min, and samples were taken every 12h for TLC monitoring during the transformation. Fermented and cultured for 96 hours, sampling was analyzed by TLC, and the conversion stagnated. The sample is extracted with ethyl acetate, and the supernatant collected by centrifugation is analyzed by high performance liquid chromatography. The content of ADD in the fermented liquid obtained above is 16.7g/L, the content of 4-AD is 0.87g/L, and the molar conversion rate of phytosterols was 72.9%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到ADD粗品,粗品再用甲苯打浆精制,最终得到ADD精品,高效液相色谱法分析纯度为98.5%。After fermentation, inactivate the fermentation broth at 85°C, cool it to 25°C, press filter with plate and frame, extract the filter cake with dichloromethane, and then obtain the crude ADD product through filtration, decolorization and distillation, and refine the crude product with toluene , and finally obtain the ADD fine product, the purity of which is 98.5% by high performance liquid chromatography.
对比实施例2Comparative Example 2
玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的菌株制成种子液(方法同实施例1),然后进行发酵培养。The bacterial strain of Rhodococcus rhodochrous (CGMCC4.1480) is prepared into seed liquid (the method is the same as in Example 1), and then fermented.
发酵培养基如实施例2所述,底物由35.0g/L的植物甾醇换成24.0g/L的ADD。将装有发酵培养基的发酵罐于121℃高压蒸汽灭菌15min。The fermentation medium was as described in Example 2, and the substrate was changed from 35.0 g/L phytosterol to 24.0 g/L ADD. The fermenter containing the fermentation medium was sterilized by high-pressure steam at 121° C. for 15 minutes.
培养初始在培养基中加入复合促溶剂:乙醇31.0g/L,聚乙二醇9.0g/L。再进行接种,玫瑰色红球菌Rhodococcusrhodochrous(CGMCC4.1480)的接种量为18.0%,使用5L发酵罐进行生物转化,装液量为70%,通气量为1.0v/v·min,温度控制在30℃,转速为300r/min,转化期间每隔12h取样TLC监测。发酵培养72h,取样TLC分析,无ADD斑点,转化基本完成。样品用乙酸乙酯萃取,离心收集上清液采用高效液相色谱法分析上述所得的发酵液中9α-OH-ADD的含量为22.6g/L,ADD摩尔转化率为93.8%。At the beginning of the culture, a compound solubilizing agent was added to the medium: ethanol 31.0 g/L, polyethylene glycol 9.0 g/L. Carry out inoculation again, the inoculum size of Rhodococcus rhodochrous (CGMCC4.1480) is 18.0%, uses 5L fermenter to carry out biotransformation, and liquid filling capacity is 70%, and ventilation rate is 1.0v/v min, and temperature is controlled at 30 °C, the rotational speed was 300r/min, and samples were taken every 12h for TLC monitoring during the conversion period. Fermented and cultured for 72 hours, sampled for TLC analysis, there was no ADD spot, and the transformation was basically completed. The sample was extracted with ethyl acetate, and the supernatant collected by centrifugation was analyzed by high performance liquid chromatography. The content of 9α-OH-ADD in the fermentation broth obtained above was 22.6g/L, and the molar conversion rate of ADD was 93.8%.
发酵结束后,将发酵液85℃灭活,冷却到25℃后,板框压滤,滤饼用二氯甲烷萃取,再经过滤、脱色及蒸馏等工序得到9α-OH-ADD粗品,粗品再用甲苯打浆精制,最终得到9α-OH-ADD精品,高效液相色谱法分析纯度为99.1%。After the fermentation, the fermentation liquid was inactivated at 85°C, cooled to 25°C, plate and frame filter press, the filter cake was extracted with dichloromethane, and the crude product of 9α-OH-ADD was obtained through filtration, decolorization and distillation. It was refined by beating with toluene to finally obtain the refined product of 9α-OH-ADD, the purity of which was analyzed by high performance liquid chromatography was 99.1%.
通过实施例可知,一步法与两步法相比,一步法具有以下优势:As can be seen from the examples, the one-step method has the following advantages compared with the two-step method:
①有助于提高植物甾醇的转化效率。如对比实施例1和2所述,两步法生物转化植物甾醇制备9α-OH-ADD,植物甾醇终摩尔转化率为72.9%×93.8%=68.4%;而如实施例2所述,一步法生物转化植物甾醇制备9α-OH-ADD,植物甾醇摩尔转化率高达84.3%。①It helps to improve the conversion efficiency of phytosterols. As described in Comparative Examples 1 and 2, the two-step method biotransforms phytosterols to prepare 9α-OH-ADD, and the final molar conversion rate of phytosterols is 72.9%×93.8%=68.4%; and as described in Example 2, the one-step method The biotransformation of phytosterols to prepare 9α-OH-ADD has a molar conversion rate of phytosterols as high as 84.3%.
②有助于缩短发酵周期。如对比实施例1和2所述,两步法微生物转化时间约为168h,而如实施例2所述,一步法混合发酵生产9α-OH-ADD生物转化时间约为96h,一步法的生物转化时间比两步法缩短了约72h。②It helps to shorten the fermentation cycle. As described in Comparative Examples 1 and 2, the two-step microbial transformation time is about 168h, and as described in Example 2, the one-step mixed fermentation produces 9α-OH-ADD biotransformation time is about 96h, and the biotransformation time of the one-step method The time is shortened by about 72h compared with the two-step method.
③降低溶媒使用量。一步法去掉了两步法中ADD的提取纯化过程,使两步提纯变为一步,减少溶剂用量,降低了生产成本。③Reduce the amount of solvent used. The one-step method removes the extraction and purification process of ADD in the two-step method, makes the two-step purification into one step, reduces the amount of solvent used, and reduces the production cost.
④减少主要副产物4-AD及9α-OH-AD的产生。通过实施例2与对比实施例1的比较可以看出,利用分枝杆菌对植物甾醇进行单菌生物转化时,同时会有ADD和4-AD的生成,且两者的质量比约为19:1。而利用两种菌混合发酵生产9α-OH-ADD时,同时会有9α-OH-ADD与9α-OH-AD的生成,且两者的质量比约为107:1。即一步法混菌转化植物甾醇生产9α-OH-ADD可以有效的减少副产物4-AD及9α-OH-AD的产生,其羟基化过程更加有利于植物甾醇向ADD方向转化,提高植物甾醇的利用效率。④Reduce the production of main by-products 4-AD and 9α-OH-AD. By the comparison of Example 2 and Comparative Example 1, it can be seen that when utilizing mycobacteria to carry out single bacterium biotransformation to phytosterols, there will be the generation of ADD and 4-AD simultaneously, and the mass ratio of the two is about 19: 1. However, when 9α-OH-ADD is produced by mixed fermentation of two kinds of bacteria, 9α-OH-ADD and 9α-OH-AD will be produced at the same time, and the mass ratio of the two is about 107:1. That is, the one-step method of mixed bacteria transformation of phytosterols to produce 9α-OH-ADD can effectively reduce the production of by-products 4-AD and 9α-OH-AD, and its hydroxylation process is more conducive to the conversion of phytosterols to ADD, improving the production of phytosterols. usage efficiency.
上述内容仅为本发明构思下的基本说明,而依据本发明的技术方案所作的任何等效变换,均应属于本发明的保护范围。The above content is only a basic description of the concept of the present invention, and any equivalent transformation made according to the technical solution of the present invention shall belong to the protection scope of the present invention.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510666412.3A CN105219829B (en) | 2015-10-15 | 2015-10-15 | A method of preparing 9 Alpha-hydroxies-androstane -1,4- diene -3,17- diketone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510666412.3A CN105219829B (en) | 2015-10-15 | 2015-10-15 | A method of preparing 9 Alpha-hydroxies-androstane -1,4- diene -3,17- diketone |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN105219829A true CN105219829A (en) | 2016-01-06 |
| CN105219829B CN105219829B (en) | 2019-03-05 |
Family
ID=54989095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510666412.3A Expired - Fee Related CN105219829B (en) | 2015-10-15 | 2015-10-15 | A method of preparing 9 Alpha-hydroxies-androstane -1,4- diene -3,17- diketone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105219829B (en) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108913643A (en) * | 2018-08-01 | 2018-11-30 | 天津科技大学 | A method of it improving mycobacteria regenerating coenzyme and androstenedione is promoted to produce simultaneously |
| CN109355345A (en) * | 2018-11-22 | 2019-02-19 | 安徽建筑大学 | A method for synthesizing androst-4-ene-3,7-dione by utilizing mycobacteria to degrade phytosterol |
| CN109652338A (en) * | 2019-01-24 | 2019-04-19 | 天津科技大学 | The mycobacterium fortutitum of 9 α-OH-AD of high yield and its application |
| CN111194825A (en) * | 2018-11-16 | 2020-05-26 | 中国科学院天津工业生物技术研究所 | A kind of harmless treatment method of steroid bacteria residue |
| CN114672427A (en) * | 2021-10-26 | 2022-06-28 | 郑州大学 | Mycobacterium for producing androstane-1, 4 diene-3, 17-dione and application thereof |
| CN114854636A (en) * | 2022-05-22 | 2022-08-05 | 郑州大学 | Method for producing androstane-1, 4-diene-3, 17-dione (ADD) by immobilizing mycobacterium |
| CN115433698A (en) * | 2022-10-18 | 2022-12-06 | 湖北共同药业股份有限公司 | A kind of mycobacterium smegmatis bacterial liquid and its preparation method and its application in the preparation of steroid drug intermediates |
| CN115537446A (en) * | 2022-09-06 | 2022-12-30 | 天津中医药大学 | Application of rhodococcus aetherivorans in production of 4-androstenedione by converting cholesterol |
| CN119931969A (en) * | 2024-12-25 | 2025-05-06 | 湖北共同甾体药物研究院有限公司 | A dehydrogenase and a method for synthesizing 11α-OH-ADD |
| CN120173832A (en) * | 2025-05-21 | 2025-06-20 | 沈阳博泰生物制药有限公司 | Mycobacterium neogoldenum and its use in preparing steroid drug intermediates |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102827913B (en) * | 2012-08-31 | 2014-01-15 | 湖南成大生物科技有限公司 | Method for preparing 11 alpha-OH-ADD by mixed fermentation of microbes |
| CN104388515A (en) * | 2014-11-28 | 2015-03-04 | 江西赣亮医药原料有限公司 | Method for producing 11alpha-OH-ADD from phytosterol by mixed fermentation |
-
2015
- 2015-10-15 CN CN201510666412.3A patent/CN105219829B/en not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108913643A (en) * | 2018-08-01 | 2018-11-30 | 天津科技大学 | A method of it improving mycobacteria regenerating coenzyme and androstenedione is promoted to produce simultaneously |
| CN111194825A (en) * | 2018-11-16 | 2020-05-26 | 中国科学院天津工业生物技术研究所 | A kind of harmless treatment method of steroid bacteria residue |
| CN109355345A (en) * | 2018-11-22 | 2019-02-19 | 安徽建筑大学 | A method for synthesizing androst-4-ene-3,7-dione by utilizing mycobacteria to degrade phytosterol |
| CN109652338A (en) * | 2019-01-24 | 2019-04-19 | 天津科技大学 | The mycobacterium fortutitum of 9 α-OH-AD of high yield and its application |
| CN109652338B (en) * | 2019-01-24 | 2021-04-09 | 天津科技大学 | Mycobacterium fortuitum for high yield of 9 alpha-OH-AD and application thereof |
| CN114672427A (en) * | 2021-10-26 | 2022-06-28 | 郑州大学 | Mycobacterium for producing androstane-1, 4 diene-3, 17-dione and application thereof |
| CN114854636A (en) * | 2022-05-22 | 2022-08-05 | 郑州大学 | Method for producing androstane-1, 4-diene-3, 17-dione (ADD) by immobilizing mycobacterium |
| CN115537446A (en) * | 2022-09-06 | 2022-12-30 | 天津中医药大学 | Application of rhodococcus aetherivorans in production of 4-androstenedione by converting cholesterol |
| CN115433698A (en) * | 2022-10-18 | 2022-12-06 | 湖北共同药业股份有限公司 | A kind of mycobacterium smegmatis bacterial liquid and its preparation method and its application in the preparation of steroid drug intermediates |
| CN119931969A (en) * | 2024-12-25 | 2025-05-06 | 湖北共同甾体药物研究院有限公司 | A dehydrogenase and a method for synthesizing 11α-OH-ADD |
| CN120173832A (en) * | 2025-05-21 | 2025-06-20 | 沈阳博泰生物制药有限公司 | Mycobacterium neogoldenum and its use in preparing steroid drug intermediates |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105219829B (en) | 2019-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105219829A (en) | A kind of method preparing 9 Alpha-hydroxies-Androsta-1,4-diene-3,17-dione | |
| CN103571897A (en) | Vitamin K2 and preparation process thereof | |
| CN101095710B (en) | A method for fermenting and improving the main functional components of Panax notoginseng | |
| CN103352062B (en) | Method for preparing glycyrrhetinic acid monoglucuronide | |
| CN106967775B (en) | Method for biocatalytic preparation of diosgenin and bacterial agent used therefor | |
| CN102888351B (en) | Prodigiosin high-producing strain and production method thereof | |
| CN108330044A (en) | A method of wine brewing yellow water recycling | |
| CN101358173B (en) | Aspergillus niger ZJUT712 and its application in processing burdock fruit by solid-state fermentation | |
| CN101928671B (en) | Alternaria spp and method thereof for preparing ginsenoside Rg3 from fermented ginseng stem-leaf total saponin | |
| CN115537446A (en) | Application of rhodococcus aetherivorans in production of 4-androstenedione by converting cholesterol | |
| CN101220334B (en) | Mucor volvulus strain, its cultivation method and its application in biotransformation of C21, C19 steroids and azasteroids | |
| CN103255191A (en) | Double liquid phase fermentation method for degrading plant sterol and preparing androstenedione | |
| CN106319016B (en) | A kind of method for preparing 11α,17α-hydroxyprogesterone | |
| WO2008145071A1 (en) | A method of fermentation production of coenzyme q10 | |
| CN102703329B (en) | A strain for efficiently transforming saponin in turmeric to produce diosgenin and its application | |
| CN104328159A (en) | Preparation method of 1,4,9(11)-triene-androst-3,17-dione | |
| CN102363796B (en) | Method for producing glycyrrhetinic acid through microbial fermentation transformation | |
| CN114395494B (en) | Saberlin Dener yeast T52 and application thereof | |
| CN111500498A (en) | A kind of new mycobacterium aureus and use thereof | |
| CN103627769A (en) | Double liquid phase fermentation method for preparing androstenedione by degrading plant sterol and | |
| CN105821086B (en) | Process for producing pravastatin on large scale | |
| CN112608971A (en) | Method for preparing hydrocortisone by multiple rounds of fermentation of resting cells | |
| CN103484375A (en) | Fusarium oxysporum SC1301 capable of biologically synthesizing testolactone, and synthesis method | |
| CN102703542A (en) | Method for synthesizing lactobionic acid by ultrasound field assisted microbial transformation | |
| CN113249226B (en) | A fermentation method for increasing the biomass and total triterpene content of Phellinus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20190305 Termination date: 20211015 |